NCT02719418View on ClinicalTrials.gov

Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

December 12, 2018

Conditions

Renal Insufficiency, ChronicDeep Venous Thrombosis, Protection Against

Interventions

DRUG

Tinzaparin

3500 Unit or 4500 Unit subcutaneous once daily

Trial Locations (1)

H1T 2M4

Maisonneuve-Rosemont Hospital, Montreal

All Listed Sponsors

lead

Maisonneuve-Rosemont Hospital

OTHER

NCT02719418 - Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses | Biotech Hunter | Biotech Hunter